Transplant Solution

Reimagine your transplant workflow by consolidating your complete test menu on one single high throughput platform.

Information for Healthcare Professionals

Lab technician putting test tubes into equipment

Simplify the Future of Transplant Testing

An innovative solution designed to expand your transplant capabilities and simplify, standardise and accelerate testing, now and into the future. Every moment matters when it comes to protecting immunocompromised patients.

Advanced Automation

Integrate and consolidate your transplant, viral load, respiratory, STI and women’s health testing on a single, fully automated high throughput system, unlocking flexibility and operational efficiency.1

Precision & Flexibility

The high performing Aptima CMV Quant assay is clinically validated for whole blood and plasma on the fully automated, high throughout Panther® System, giving labs the versatility and precision to detect, diagnose and deliver results.2   

Confidence & Control

The launch of Panther® Fusion EBV Quant and BKV Quant Assays continues our promise of innovation across critical post-transplant monitoring.3,4

Proven Performance

40.7 IU/mL

Limit of detection (LoD)2*
Plasma
Aptima® CMV Quant Assay

43.1 IU/mL

Limit of detection (LoD)3**
Plasma
Panther Fusion® BKV Quant Assay

54.1 IU/mL

Limit of detection (LoD)4**
Plasma
Panther Fusion® EBV Quant Assay

One Solution. Infinite possibilities

Hologic’s Molecular Scalable Solutions now has a fully automated Transplant Solution, combining a large IVD assay portfolio with advanced automation.

Insights

Healthcare provider looking at scan images on monitor display

FDA Market Authorisation for Genius™ Digital Diagnostics System

Cervical screening infographics

Discover the Future of Cervical Cancer Screening

PCR tests in a rack held by a hand wearing gloves.

The Molecular Diagnostics Revolution and Its Impact on Personalised Care

Simplify & Scale the Future of Diagnostics

The Transplant Solution is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high performing assay menu with high throughput automation. Designed to flexibly scale to meet your needs, from a single patient result to population level screening.

Technician walking by Panther Systems in a lab setting
    *Established using the 1st WHO International Standard
    **Established using the 1st WHO International Standard. High correlation against a comparator assay on retrospective and contrived plasma and urine specimens across the linear range of the assay.
    1. Panther/Panther Fusion System Operator´s Manual. AW-26055-001 Rev 001, San Diego, CA: Hologic Inc.; 2022.
    2. Aptima CMV Quant Assay [package insert]. AW-25509-001 Rev 003, San Diego, CA: Hologic, Inc.; 2022.     
    3. Panther Fusion BKV Quant Assay [package insert]. AW-26020-001 Rev 001, San Diego, CA: Hologic, Inc.; 2022        
    4. Panther Fusion EBV Quant Assay [package insert]. AW-26019-001 Rev 002, San Diego, CA: Hologic, Inc.; 2023

    Related Portfolios & Solutions

    Female lab technician carrying a tray of specimens to insert into Panther system
    Portfolio

    Molecular Scalable Solution

    A scalable portfolio combining a broad, high performing assay menu with high throughput automation. Designed to flexibly scale to meet your needs, from a single patient result to population level screening.

    Gloved hand taking specimen out from tray
    Portfolio

    Cervical Health

    From HPV to cytology, and now also AI based digital diagnostics, we offer a comprehensive screening portfolio, from sample collection to diagnosis.

    Solution

    High-Throughput Testing

    Solution

    Respiratory

    Solution

    STI

    Solution

    Virology

    Solution

    Transplant

    Solution

    HPV

    Solution

    Vaginal health

    Solution

    Hospital Acquired Infections

    Solution

    In House IVDs

    Solution

    Collection Devices

    1434

    2797

    Hologic BV, DA Vincilaan 5, 1930 Zaventem, Belgium

    Notified Body number wherever applicable
    EC Representative Information wherever applicable